Approval · Notice of Compliance 17967 · 2016
PARNATE: Notice of Compliance 17967
Issued April 7, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17967
- Date
- April 7, 2016
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product mongraph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PARNATE | Not yet assigned | — |
Medicinal ingredients
- TRANYLCYPROMINE SULFATE 10 MG per TAB